Search

everythinglearnresearchcommunity

for

Search:↓

Scarred skin in lichen planopilaris loses immune cells due to a decrease in a specific protein in skin cells.

Mixing platelet-rich plasma with Poly-D,L-Lactic Acid helps reduce deep lines around the nose and mouth.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

A new treatment using unactivated platelet leukocyte autoplasma cured 80% of non-scarring alopecia patients.

The P&P Hairline Laser is a new, hands-free device that improves hairline symmetry in hair restoration surgery and can create a symmetrical hairline in less than a minute.

LC-OCT is an effective new method for diagnosing classic lichen planopilaris.

LL-37 helps stem cells grow and move, aiding tissue regeneration and hair growth.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Platelet-rich plasma is a safe and effective treatment for oral lichen planus.

Basement membrane changes in lichen planopilaris cause scarring and permanent hair loss.

PRP treatment improved skin pigmentation and appearance in facial lichen planus pigmentosus.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

Early diagnosis and treatment of Lichen Planopilaris are crucial to prevent permanent hair loss.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Lichen planus pigmentosus and fibrosing frontal alopecia in Colombia are likely different stages of the same disease.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

AFM can help diagnose lichen planopilaris by identifying specific hair structure changes.

Scalp edema may be a new variant of conditions reacting to scarring alopecia like LPP.

Lipid-polymer hybrid nanoparticles show promise for skin treatments but need better formulation strategies.

Poly-D,L-lactic acid boosts hair growth in aged skin by activating hair follicle stem cells.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Dermoscopy helps diagnose rare GLPLS in males.